A large-scale study aimed at collecting and analyzing data on neuroimaging, genetics, biomarkers, and cognitive function in patients with Alzheimer’s disease and other memory disorders. The goal of ADNI is to better understand the mechanisms of Alzheimer’s disease progression and to develop methods for early diagnosis, as well as to create tools to assess the effectiveness of treatment. Uses a variety of neuroimaging technologies, such as MRI, PET, and other techniques, to monitor changes in the brain that may be associated with the development of Alzheimer’s disease. In addition, the project collects genetic and biochemical data that helps researchers identify possible biomarkers of the disease.The study is an important resource for scientists, clinicians and pharmaceutical companies working in the field of dementia and neurodegenerative diseases, and helps accelerate the search for new methods for diagnosing and treating Alzheimer’s disease.